| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Animal Blood Product Market Size 2024 |
USD 4735 million |
| Animal Blood Product Market, CAGR |
7.4% |
| Animal Blood Product Market Size 2032 |
USD 8382.1 million |
Market Overview:
The Animal Blood Product Market size was valued at USD 4735 million in 2024 and is anticipated to reach USD 8382.1 million by 2032, at a CAGR of 7.4% during the forecast period (2024-2032).
Key drivers propelling market growth include the rising prevalence of animal diseases such as anemia, liver disorders, and blood loss, which necessitate the use of blood products for treatment and management. Additionally, the growing demand for personalized veterinary care is further driving the need for animal blood products tailored to specific conditions. Furthermore, the growing adoption of advanced diagnostic tools and therapeutic solutions, particularly in veterinary hospitals and animal research laboratories, has amplified the need for high-quality animal blood products. The increasing number of pet ownership, especially in developed regions, combined with expanding awareness about animal welfare and the importance of timely medical intervention, is further bolstering market expansion. Additionally, the development of innovative technologies for blood collection, processing, and preservation is enhancing the efficacy and availability of animal blood products, enabling broader accessibility across diverse veterinary practices.
Regionally, North America dominates the global animal blood products market, holding the largest market share due to advanced healthcare infrastructure, a high concentration of veterinary clinics, and the growing focus on animal health. The United States is a key player in this market, driven by the increasing demand for blood products in both pets and livestock, with a focus on improving animal health standards. Europe is also experiencing substantial market growth, driven by rising veterinary care expenditures and government initiatives aimed at improving animal healthcare standards, particularly in nations like Germany and the UK, which are investing in advanced veterinary technologies. The Asia Pacific region is anticipated to witness significant growth due to the increasing animal population and improvements in veterinary services in emerging economies, with China and India leading the growth in animal healthcare demand.
Market Insights:
- The Animal Blood Product Market was valued at USD 4,735 million in 2024 and is anticipated to reach USD 8,382.1 million by 2032, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period (2024-2032).
- The increasing prevalence of animal diseases such as anemia, liver disorders, and infections is driving the demand for blood products in veterinary treatments.
- The rising demand for personalized veterinary care is accelerating the need for tailored blood products to address specific animal health conditions.
- Advancements in veterinary diagnostic tools and therapeutic solutions are boosting the need for high-quality animal blood products, improving treatment outcomes.
- Rising pet ownership, particularly in developed regions, is pushing the demand for animal blood products as pet owners seek more specialized and timely veterinary care.
- Innovations in blood collection, processing, and preservation technologies are improving the quality, availability, and shelf life of animal blood products.
- North America leads the market, with the U.S. driving demand due to its high pet population, established veterinary services, and continuous investments in animal healthcare.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
Download Sample
Market Drivers:
Increasing Incidence of Animal Diseases
The rising prevalence of animal diseases, including anemia, liver disorders, and infections, is a significant driver for the Animal Blood Products Market. Blood products such as plasma, red blood cells, and platelets are vital in the treatment of these diseases, particularly in veterinary hospitals. These diseases not only affect pets but also livestock, increasing the need for blood products across different sectors. The need for timely intervention and specialized blood products ensures better recovery rates and promotes the overall welfare of animals. This growing demand for blood products in both companion and farm animals further fuels market growth.
Advancement in Veterinary Care and Diagnostic Tools
The increasing adoption of advanced veterinary care, including diagnostic tools and therapeutic solutions, directly impacts the Animal Blood Products Market. These innovations help veterinarians make more accurate diagnoses and provide more effective treatments, which in turn drives the need for animal blood products. The introduction of advanced medical technologies, such as portable diagnostic devices and improved laboratory equipment, enhances the scope of blood product usage, ensuring better outcomes in animal healthcare. This technological advancement also contributes to the efficiency and speed of blood transfusion processes, improving patient care.
- For instance, Magnomics developed a portable PCR diagnostic device incorporating four patented technologies that processes DNA samples for pathogen detection within a single microfluidic cartridge, delivering results without training in under 30 minutes.
Rising Pet Ownership and Welfare Awareness
The rising trend of pet ownership, particularly in developed regions, is accelerating the demand for animal blood products. Pet owners are increasingly seeking high-quality medical care for their animals, pushing the demand for blood products used in treatments. As awareness about animal welfare grows, pet owners are more inclined to provide timely and effective medical care, contributing to market expansion. Veterinary clinics and hospitals, catering to the needs of pets, further increase the utilization of these products. This increasing awareness also supports the adoption of preventive care, which may require blood products for diagnostics and treatment.
- For instance, in 2025, 94 million U.S. households reported owning at least one pet, with 68 million dog-owning households and 49 million cat-owning households, reflecting a clear demand for high-quality veterinary and blood-based medical treatments.
Innovations in Blood Collection and Preservation
The development of innovative technologies in blood collection, processing, and preservation is enhancing the availability and quality of animal blood products. These advancements ensure longer shelf life and improved compatibility of blood products for various animal species. New techniques also improve the safety and efficiency of blood transfusion procedures, promoting their adoption across veterinary hospitals and research institutions. Additionally, these innovations reduce the risk of contamination and improve the overall quality of stored blood, enhancing its usability in critical treatments.
Market Trends:
Growth of Blood Substitutes in Veterinary Medicine
The demand for blood substitutes is gaining traction within the Animal Blood Products Market. These substitutes, such as hemoglobin-based oxygen carriers and perfluorocarbons, are becoming essential in treating animals that require blood transfusions but lack access to fresh blood. These substitutes are considered safer and more efficient, offering longer shelf lives and easier storage. Their growing use in veterinary hospitals is expected to continue as more advancements are made in their formulations and applications. This trend is driven by their ability to provide immediate relief in emergency situations, especially in cases where blood donations are unavailable.
- For instance, Oxyglobin®, developed by HbO2 Therapeutics, is the only hemoglobin-based oxygen carrier approved in the United States and Europe for veterinary use, with a room temperature shelf life of at least three years, compared to just six weeks for refrigerated red blood cells.
Integration of Biotechnological Advancements
Biotechnological innovations are transforming the Animal Blood Products Market, particularly through genetic engineering and the development of synthetic blood products. Companies are focusing on developing blood products with enhanced functionality and lower risks of immunological reactions. This trend reflects a shift towards more personalized and precise veterinary care. The market is also seeing the introduction of blood products that cater to specific breeds or genetic conditions, which are becoming increasingly popular in specialized veterinary treatments. These advancements in biotechnology also open doors to alternative solutions, such as lab-grown blood, which could address supply limitations.
- For instance, ToolGen Inc., in partnership with Lartbio, successfully developed a gene-edited cow using CRISPR gene-editing technology in 2023; this animal was engineered specifically to remove key antigens in the immune system, producing artificial blood for research and addressing immune rejection, with the first live gene-edited cow publicly announced by both companies in June 2023.
Market Challenges Analysis:
High Costs of Blood Products and Preservation
The Animal Blood Products Market faces challenges related to the high costs of sourcing, processing, and preserving blood products. Due to the complex procedures involved in collecting and storing blood, the prices of animal blood products remain relatively high. Smaller veterinary clinics may struggle to afford these products, potentially limiting their availability in certain regions. The cost barrier also affects the accessibility of advanced blood treatments, particularly in emerging markets. Efforts to streamline production processes and reduce costs could help alleviate this challenge and make blood products more accessible to a wider audience.
Shortage of Donor Animals
Another significant challenge for the Animal Blood Products Market is the shortage of donor animals. Despite the growing demand for animal blood products, the supply remains constrained due to the limited number of animals available for blood donation. This shortage limits the ability of blood banks to meet the rising demand, particularly in areas with high animal populations or limited access to veterinary services. Innovative solutions, such as blood donation programs and improved blood collection methods, are being explored to address this issue, but it remains a challenge for the market.
Market Opportunities:
Expansion of Veterinary Services in Emerging Economies
Emerging economies are presenting significant opportunities for the Animal Blood Products Market. As veterinary services expand in countries such as China, India, and Brazil, the demand for animal blood products is expected to grow substantially. Increasing urbanization and the rise of pet ownership in these regions contribute to the market’s expansion. Veterinary clinics and hospitals are becoming more accessible, offering a wider range of services, including blood transfusions and other critical treatments. The expanding middle class in these regions is also contributing to higher spending on pet care, further boosting the demand for animal blood products.
Advancements in Blood Product Alternatives
The growing interest in alternative blood products, including synthetic blood and blood substitutes, presents a key opportunity for the Animal Blood Products Market. These products offer enhanced safety, longer shelf life, and greater storage flexibility, addressing some of the challenges associated with traditional blood products. As research into these alternatives progresses, their adoption in veterinary practices will likely increase, opening new avenues for growth in the market. These innovations provide a potential solution to the ongoing challenges of donor animal shortages and could play a crucial role in meeting the demand for animal blood products.
Market Segmentation Analysis:
By Product Type
The Animal Blood Products Market is primarily segmented into plasma, red blood cells, and platelets. Plasma holds the largest market share due to its widespread use in treating various medical conditions such as anemia, shock, and blood loss. Red blood cells are also crucial for managing anemia and restoring blood volume, while platelets are essential in treating clotting disorders. The demand for plasma-based products continues to grow, driven by their use in both veterinary care and animal research.
By Animal Type
The market is segmented by animal type into companion animals, livestock, and others. Companion animals, particularly pets such as dogs and cats, hold the largest share due to the growing pet ownership and demand for specialized veterinary care. Livestock, including cattle, horses, and swine, also contributes significantly to the market, driven by the need for blood products in managing disease and ensuring animal health. The increasing focus on livestock health and welfare across the globe supports continued demand for blood products in this segment.
- For instance, Pet Blood Bank UK operates 24 hours a day, seven days a week, ensuring blood is always available for veterinary practitioners and saving the lives of thousands of dogs nationwide each year.
By Source Animal Type
The Animal Blood Products Market is further segmented by source animal type, including bovine, equine, porcine, and others. Bovine blood products dominate the market due to their extensive use in both livestock and companion animal treatments. Equine and porcine blood products are also significant, particularly in specialized veterinary care for horses and swine. The availability of blood from these source animals supports a wide range of therapeutic applications in veterinary practices globally.
- For instance, APC distributed spray-dried plasma produced across 17 global manufacturing sites in 2024 for incorporation in pet food and livestock feed.
Segmentations:
- By Product Type
- Plasma
- Red Blood Cells
- Platelets
- By Animal Type
- Companion Animals
- Livestock
- Others
- By Source Animal Type
- Bovine
- Equine
- Porcine
- Others
- By End-User
- Veterinary Hospitals
- Research Institutes
- Animal Blood Banks
- Others
- By Distribution Channel
- Direct Sales
- Veterinary Clinics
- Online Sales
- Others
- By Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis:
North America Leading the Animal Blood Products Market
North America holds a dominant share of 40% of the global Animal Blood Products Market. The United States is a key player, where the demand for animal blood products is driven by the growing pet population and livestock management practices. Veterinary services in North America are well-established, making blood transfusions and other critical treatments widely accessible. Furthermore, ongoing investments in animal healthcare and the increasing awareness of animal welfare further bolster the market’s expansion. The region’s robust research and development activities also support the innovation of new blood products, enhancing their efficiency and safety in veterinary treatments.
Europe Significant Growth in Animal Blood Products Demand
Europe holds a substantial market share of 30% in the Animal Blood Products Market. The region experiences consistent growth driven by rising veterinary care expenditures and a strong focus on animal health. Countries such as the United Kingdom, Germany, and France have contributed to the demand for high-quality animal blood products, responding to the growing pet ownership trend and the need for effective disease management in both companion animals and livestock. European veterinary clinics and hospitals are increasingly incorporating advanced blood products into their services. Government initiatives to support animal health and welfare further promote the adoption of blood products, fostering market growth.
Asia-Pacific Rapid Market Expansion with Untapped Potential
The Asia-Pacific region holds a growing share of 20% in the global Animal Blood Products Market. It is witnessing rapid expansion driven by increasing animal populations and advancements in veterinary healthcare. Emerging economies such as China, India, and Southeast Asian countries are investing heavily in improving veterinary services, contributing to the rising demand for animal blood products. The increasing adoption of pets, particularly in urban areas, coupled with growing awareness about animal health, is fueling market expansion. The region’s untapped potential offers substantial opportunities for growth, as veterinary clinics and hospitals enhance their capabilities to meet the rising demand for specialized treatments. The market is expected to grow substantially as animal healthcare standards improve in these developing economies.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis:
- PAN-Biotech
- R&D Systems
- Merck
- Bovogen
- Biowest
- Moregate BioTech
- Gemini
- Thermo Fisher
- Inteegocios
- Tissue Culture Biologicals
- RMBIO
- VWR
- Coing
- Cytiva
- Biological Industries
Competitive Analysis:
The Animal Blood Product Market is competitive, with key players like Hemostasis, Grifols, and Vet Blood Bank leading the sector. These companies focus on product innovation, quality, and strong distribution networks to meet the growing demand for veterinary blood products. Smaller players often specialize in niche markets, providing customized solutions for specific animal species or conditions. Strategic collaborations with veterinary institutions enhance market presence and access to critical blood products. With rising pet ownership and increased veterinary care, the competition intensifies. Companies differentiate by offering superior supply chain logistics and advanced blood preservation techniques, aiming to expand their market share and improve access to blood products across diverse regions.
Recent Developments:
- In July 2025, Merck launched the AAW™ Automated Assay Workstation, an automation platform powered by Opentrons to streamline lab workflows for academia, pharma, and biotech.
- In July 2025, Merck announced the acquisition of Verona Pharma for approximately $10 billion, adding the COPD drug Ohtuvayre (ensifentrine) to its cardio-pulmonary portfolio.
- In May 2025, Cytiva announced a collaboration with Nuclera to accelerate the production, purification, and characterization of proteins for drug research and development, combining Nuclera’s eProtein Discovery System with Cytiva’s Biacore surface plasmon resonance technology.
Market Concentration & Characteristics:
The Animal Blood Product Market is moderately concentrated, with a few large players holding a significant market share. Companies like Hemostasis, Grifols, and Vet Blood Bank dominate, focusing on broad product portfolios and robust distribution channels. Smaller companies often target specific niches, offering specialized products for unique veterinary needs or rare animal species. The market is characterized by a strong emphasis on product innovation, with a growing demand for blood products driven by the rise in veterinary procedures and pet ownership. Companies prioritize high-quality standards, regulatory compliance, and strategic partnerships to strengthen their market positions. The increasing reliance on advanced blood preservation techniques and logistics further defines the competitive landscape. While competition remains intense, the market benefits from steady demand, particularly in regions with high pet ownership and veterinary care rates.
Report Coverage:
The research report offers an in-depth analysis based on Product Type, Animal Type, Source Animal Type, End-User, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- The Animal Blood Product Market is expected to witness sustained growth driven by increasing demand for veterinary care and improved animal health awareness.
- The rising prevalence of chronic animal diseases such as anemia and liver disorders will continue to fuel the need for blood products in veterinary treatments.
- Technological advancements in blood collection, processing, and preservation will enhance the quality and availability of animal blood products.
- The adoption of personalized veterinary care will drive demand for tailored blood products to treat specific conditions in animals.
- Increased investment in animal healthcare infrastructure, particularly in developing regions, will open new growth opportunities for the market.
- The expansion of pet ownership in developed and emerging markets will further boost demand for high-quality animal blood products.
- Veterinary hospitals and research institutions will increasingly adopt advanced diagnostic tools and therapies, driving the need for high-quality blood products.
- Strategic collaborations and partnerships among key players will strengthen distribution channels and improve product accessibility.
- The focus on sustainable practices in blood product sourcing and processing will influence market development.
- Growing government initiatives to improve animal healthcare standards, especially in North America and Europe, will continue to positively impact the market.
